Monthly Archives: July 2010

PREVIEW-New obesity pills try to shed past problems

Posted on July 13, 2010 by

[Reuters] * First of three new obesity drugs up for review July 15 * Vivus’ Qnexa targets patients with related health issues * Arena, Orexigen seeking to sell rival drugs * Pills would be first for weight-loss in a decade … Continue reading →

Posted in News | Leave a comment

Notable Analyst Upgrades, Downgrades and Comments

Posted on July 9, 2010 by

VIVUS, Inc. (NASDAQ:VVUS), Sun Bancorp, Inc. (NASDAQ:SNBC) and H&R Block, Inc. (NYSE:HRB) are three notable analyst upgrades, downgrades and comments made during today’s session. VIVUS Obesity Medication Looks Attractive VIVUS, Inc. (VVUS, Free Analysis), a developer of therapeutic products for underserved … Continue reading →

Posted in Finance | Leave a comment